Science Explorer Back to mapMap
Discussion
Hospital / health system · Lisbon · ??

Instituto Português de Reumatologia

Research works
51
▼ 67% vs 2018-21
Citations
631
12.4 per fractional work
Top-10% rate
15.7%
all institutions 10.0%
Open access
41%
world 40%
International
28%
world 18%

Not ranked overall: Instituto Português de Reumatologia is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Instituto Português de Reumatologia work in?

In all years, 85% of research at Instituto Português de Reumatologia is in Health Sciences, 10% in Life Sciences. Its largest fields are Medicine (80%), Immunology and Microbiology (5%), Biochemistry, Genetics and Molecular Biology (4%). It does 3.1× the world's share of Health Sciences.

Health Sciences: 43 fractional works · 84.9% of its workMedicine: 41 fractional works · 79.9% of its workRheumatology: 13 fractional works · 25.1% of its workOrthopedics and Sports Medicine: 4 fractional works · 6.9% of its workHematology: 3 fractional works · 6.3% of its workPsychiatry and Mental health: 3 fractional works · 5.3% of its workPhysiology: 3 fractional works · 4.9% of its workSurgery: 2 fractional works · 4.2% of its workEpidemiology: 2 fractional works · 3.7% of its workPathology and Forensic Medicine: 2 fractional works · 3.6% of its workPulmonary and Respiratory Medicine: 1 fractional works · 1.8% of its workNephrology: 1 fractional works · 1.7% of its workRehabilitation: 1 fractional works · 1.6% of its workOncology: 1 fractional works · 1.5% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 1.5% of its workEmergency Medicine: 1 fractional works · 1.4% of its workGenetics: 1 fractional works · 1.2% of its workDermatology: 1 fractional works · 1.2% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 1.1% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 1.0% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.8% of its workPharmacology: 0 fractional works · 0.7% of its workOphthalmology: 0 fractional works · 0.7% of its workImmunology and Allergy: 0 fractional works · 0.6% of its workInfectious Diseases: 0 fractional works · 0.6% of its workAnatomy: 0 fractional works · 0.5% of its workFamily Practice: 0 fractional works · 0.5% of its workGastroenterology: 0 fractional works · 0.4% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.3% of its workNeurology: 0 fractional works · 0.3% of its workComplementary and alternative medicine: 0 fractional works · 0.3% of its workHealth Professions: 2 fractional works · 3.5% of its workGeneral Health Professions: 1 fractional works · 1.6% of its workSpeech and Hearing: 1 fractional works · 1.3% of its workComplementary and Manual Therapy: 0 fractional works · 0.6% of its workDentistry: 1 fractional works · 1.3% of its workPeriodontics: 0 fractional works · 1.0% of its workGeneral Dentistry: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNursing: 0 fractional works · 0.2% of its workNutrition and Dietetics: 0 fractional works · 0.2% of its workLife Sciences: 5 fractional works · 10.4% of its workImmunology and Microbiology: 2 fractional works · 4.5% of its workImmunology: 2 fractional works · 4.5% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 3.6% of its workGenetics: 1 fractional works · 1.9% of its workMolecular Biology: 1 fractional works · 1.7% of its workSmaller subfields together: 0 fractional works · 0.0% of its workAgricultural and Biological Sciences: 1 fractional works · 1.1% of its workPlant Science: 1 fractional works · 1.1% of its workNeuroscience: 0 fractional works · 0.8% of its workEndocrine and Autonomic Systems: 0 fractional works · 0.8% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.4% of its workPharmacology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workSocial Sciences: 2 fractional works · 4.3% of its workEconomics, Econometrics and Finance: 1 fractional works · 2.1% of its workEconomics and Econometrics: 1 fractional works · 2.0% of its workSmaller subfields together: 0 fractional works · 0.1% of its workBusiness, Management and Accounting: 0 fractional works · 1.0% of its workOrganizational Behavior and Human Resource Management: 0 fractional works · 1.0% of its workSocial Sciences: 0 fractional works · 0.8% of its workPolitical Science and International Relations: 0 fractional works · 0.3% of its workSociology and Political Science: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPsychology: 0 fractional works · 0.4% of its workClinical Psychology: 0 fractional works · 0.4% of its workPhysical Sciences: 0 fractional works · 0.5% of its workEnvironmental Science: 0 fractional works · 0.3% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.3% of its workChemistry: 0 fractional works · 0.1% of its workALL ITS WORKInstitutoPortuguês de…51fractional works, all years
Life Sciences10%Physical Sciences0%Health Sciences85%Social Sciences4%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 16 fields, with their numbers
    1. Medicine4179.9%
    2. Health Professions23.5%
    3. Dentistry11.3%
    4. Nursing00.2%
    1. Immunology and Microbiology24.5%
    2. Biochemistry, Genetics and Molecular Biology23.6%
    3. Agricultural and Biological Sciences11.1%
    4. Neuroscience00.8%
    5. Pharmacology, Toxicology and Pharmaceutics00.4%
    1. Economics, Econometrics and Finance12.1%
    2. Business, Management and Accounting01.0%
    3. Social Sciences00.8%
    4. Psychology00.4%
    1. Environmental Science00.3%
    2. Chemistry00.1%
    3. Mathematics00.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.26× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 11.85× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 2.04× its world share, 0 worksPharmacology, Toxico…Mathematics: 0.31× its world share, 0 worksMathematicsHealth Professions: 1.49× its world share, 0 worksHealth ProfessionsMedicine: 4.09× its world share, 2 worksMedicineEconomics, Econometrics and Finance: 0.90× its world share, 0 worksEconomics, Econometr…Psychology: 0.37× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 11.8×. Every wedge is a field page.

All 8 fields, with their numbers
  1. Immunology and Microbiology11.85×0 works
  2. Medicine4.09×2 works
  3. Pharmacology, Toxicology and Pharmaceutics2.04×0 works
  4. Health Professions1.49×0 works
  5. Economics, Econometrics and Finance0.90×0 works
  6. Psychology0.37×0 works
  7. Mathematics0.31×0 works
  8. Biochemistry, Genetics and Molecular Biology0.26×0 works

Who are the top researchers at Instituto Português de Reumatologia?

Ranked on the quality score, Jose Antonio Melo‐Gomes lead among researchers whose main affiliation is Instituto Português de Reumatologia.

  1. 1 Jose Antonio Melo‐Gomes #389,518 worldwide 4.4k citations · 38 works
All ranked researchers at Instituto Português de Reumatologia

What are the most cited papers from Instituto Português de Reumatologia?

The most cited paper from Instituto Português de Reumatologia is "Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database" (A. J. Tyndall et al., 2010), with 1,461 citations. Next come "Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial" (563) and "Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: Two‐year clinical and radiographic results from the TEMPO study, a double‐blind, randomized trial" (545).

Most cited papers
#PaperReleasedCitations
1 Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database A. J. Tyndall et al. · Annals of the Rheumatic Diseases Open access 15 Jun 2010 1,461
2 Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial Nicolino Ruperto et al. · The Lancet 15 Jul 2008 563
3 Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: Two‐year clinical and radiographic results from the TEMPO study, a double‐blind, randomized trial Désirée M F M van der Heijde, Lars Klareskog, Vicente Rodrı́guez-Valverde et al. · Arthritis & Rheumatism 29 Mar 2006 545
4 Effects of Previous Antiresorptive Therapy on the Bone Mineral Density Response to Two Years of Teriparatide Treatment in Postmenopausal Women with Osteoporosis Steven Boonen, Fernando Marín, Barbara Maria Obermayer-Pietsch et al. · The Journal of Clinical Endocrinology & Metabolism 26 Dec 2007 253
5 Long‐term safety and efficacy of abatacept in children with juvenile idiopathic arthritis Nicolino Ruperto et al. · Arthritis & Rheumatism 26 Feb 2010 240
All 60 most cited papers, with filters and sorting

Which keywords describe research at Instituto Português de Reumatologia?

By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Autoantibodies, Treatment, Cardiovascular Risk, Biological Therapy, Cytokines, Rheumatoid Arthritis and Disease-Modifying Antirheumatic Drugs.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation12▲ 9.7×25 topics
  2. Autoantibodies10▲ 79×6 topics
  3. Treatment8▲ 12×12 topics
  4. Epidemiology6▲ 2.9×23 topics
  5. Cardiovascular Risk6▲ 32×3 topics
  6. Biological Therapy5▲ 190×2 topics
  7. Cytokines5▲ 39×3 topics
  8. Disease-Modifying Antirheumatic Drugs5▲ 210×1 topic
  9. Joint Inflammation5▲ 210×1 topic
  10. Rheumatoid Arthritis5▲ 101×2 topics
  11. Diagnostic Criteria5▲ 43×3 topics
  12. Juvenile Idiopathic Arthritis3▲ 123×2 topics
  13. Psychological Factors3▲ 32×3 topics
  14. Ankylosing Spondylitis3▲ 255×1 topic
  15. Central Sensitization3▲ 75×2 topics
  16. Spondyloarthritis3▲ 255×1 topic
  17. Hemophagocytic Lymphohistiocytosis3▲ 247×1 topic
  18. Macrophage Activation Syndrome3▲ 247×1 topic
  19. Chronic Fatigue Syndrome3▲ 213×1 topic
  20. Fibromyalgia3▲ 213×1 topic
  21. Parathyroid Hormone3▲ 52×2 topics
  22. Rheumatology3▲ 127×2 topics
  23. Bone Mineral Density2▲ 58×1 topic
  24. Fractures2▲ 110×1 topic
  25. Biomarkers2▲ 6.3×3 topics
  26. Diagnosis2▲ 3.8×12 topics
  27. Antiphospholipid Syndrome2▲ 71×1 topic
  28. Autoimmune Disease2▲ 52×2 topics
  29. Osteoarthritis2▲ 30×3 topics
  30. Systemic Lupus Erythematosus2▲ 65×1 topic
  31. Immunosuppressive Therapy2▲ 18×4 topics
  32. Lymphoma2▲ 24×2 topics
  33. Saliva2▲ 150×1 topic
  34. Salivary Gland2▲ 150×1 topic
  35. Fibrosis2▲ 17×3 topics
  36. Regeneration2▲ 18×2 topics
  37. Primary Care2▲ 7.6×5 topics
  38. Endothelial Dysfunction2▲ 10×3 topics
  39. Cartilage1▲ 62×1 topic
  40. Chondrocyte1▲ 62×1 topic

Which research topics does Instituto Português de Reumatologia publish most on?

By volume in 2022-now: Spondyloarthritis Studies and Treatments, Rheumatoid Arthritis Research and Therapies, Psoriasis: Treatment and Pathogenesis and Salivary Gland Disorders and Functions.

  1. 1 Spondyloarthritis Studies and Treatments Rheumatology 1 works
  2. 2 Rheumatoid Arthritis Research and Therapies Rheumatology 0 works
  3. 3 Psoriasis: Treatment and Pathogenesis Immunology 0 works
  4. 4 Salivary Gland Disorders and Functions Physiology 0 works
  5. 5 Spine and Intervertebral Disc Pathology Pathology and Forensic Medicine 0 works
  6. 6 Celiac Disease Research and Management Gastroenterology 0 works
  7. 7 Musculoskeletal pain and rehabilitation Pharmacology 0 works
  8. 8 Systemic Sclerosis and Related Diseases Pathology and Forensic Medicine 0 works
  9. 9 Fibromyalgia and Chronic Fatigue Syndrome Research Psychiatry and Mental health 0 works
  10. 10 Systemic Lupus Erythematosus Research Rheumatology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available41.2%not open58.8%

World: 40% of research is openly available.

with international co-authors28.3%domestic only71.7%

World: 18% is written across borders.

How has Instituto Português de Reumatologia's research output changed?

Output in 2022-2025 was 67% lower than in 2018-2021.

still counting200020052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Instituto Português de Reumatologia as a percentage of every work published that year, 0.000019% in 2024.

still counting0.00010%0.00020%0.00030%Instituto Português de Reumatologia0.000013% in 2025200020102020

Fractional works of Instituto Português de Reumatologia over all fractional works that year. How the balance of science has shifted.

Other research institutions in Lisbon

All research institutions in Lisbon

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Instituto Português de Reumatologia. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.